$INTT

InTest Expects Record Orders for Q3 2026 and Revenue at High End of Guidance Range for Q3 and Full Year 2026

INTEST CORP (INTT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Expects Record Orders for Q3 2026 and Revenue at High End of Guidance Range for Q3 and Full Year 2026 • Q3 orders 1 expected to be $48 million to $50 million, driven by r

Original reporting
Published Oct 5, 2026, 12:39 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 12:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$INTT
Bullish
high confidence
Mentioned
$INTT
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$INTTBullishMed
01

Why it matters

The guidance highlights record semiconductor demand, which could benefit peers in the test equipment space while reinforcing bullish sentiment for AI‑related hardware.

02

Market read

Guidance at the high end may trigger buying interest in INTT and related semiconductor test equipment stocks.

03

What to watch

Potential supply‑chain constraints or macro‑economic slowdown could limit the translation of orders into revenue.

Relevance 7/10Novelty 7/10Timing: today
AlphAI · Earnings readINTT · Q3 2026 · ended September 30, 2026

InTest Expects Record Orders for Q3 2026 and Revenue at High End of Guidance Range for Q3 and Full Year 2026

✓Strong quarter

Preliminary Q3 orders are expected to reach a record $48 million to $50 million, revenue is expected at the high end of the $33 million to $35 million guidance range, and backlog is expected to increase to $58 million to $60 million.

Revenue
at the high end of the Company's guidance range of $33 million to $35 million
growth of more than 30% compared with $26.2 million in the third quarter of 2025 y/y
Q3 2026 outlook
at the high end of the Company's guidance range of $33 million to $35 million

Key metrics

as reported
MetricValueq/qy/y
Q3 2026 estimated ordersother$48 million to $50 million–an increase of 28% to 33% compared with the third quarter of 2025
Q3 2026 estimated revenueotherat the high end of the Company's guidance range of $33 million to $35 million–growth of more than 30% compared with $26.2 million in the third quarter of 2025
Estimated backlog at September 30, 2026other$58 million to $60 millionup approximately 28% to 32% from $45.4 million at June 30, 2026–

Q3 2026 outlook

  • Revenueat the high end of the Company's guidance range of $33 million to $35 million
  • NoteQ3 orders expected to be $48 million to $50 million
  • NoteQ3 book-to-bill ratio expected to be above 1.3x
  • NoteBacklog at the end of Q3 expected to be $58 million to $60 million
  • NoteRevenue for the full year 2026 expected to be at the high end of the Company's guidance ranges

What drove it

  • Record back-end semiconductor orders led expected Q3 order growth.
  • Customers' capacity expansions, fueled in part by AI-driven data center demand, are driving demand for advanced semiconductor test solutions.
  • High-powered chillers and advanced manipulators are contributing substantially by addressing rising power conversion requirements and growing mixed-signal and analog test needs.
  • Orders for semiconductor and other end-markets booked in prior quarters are now shipping.

Concerns

  • The selected financial results are preliminary and subject to completion of the Company's financial closing procedures.
  • Actual results may vary materially from the selected preliminary financial results.
  • Order levels may vary from quarter to quarter with the timing of customers' capital investments.
  • Contracts may include provisions for cancellation, termination, or suspension at the discretion of the customer.
  • The Company cites risks including supply chain challenges, backlog conversion and timely shipment, semiconductor-demand changes, and a material weakness in internal controls over financial reporting.

What to watch

  • Final third quarter 2026 results, which the Company expects to report on November 6, 2026.
  • Whether estimated orders of $48 million to $50 million and backlog of $58 million to $60 million are confirmed following financial closing procedures.
  • Conversion of semiconductor and other end-market backlog into revenue.
  • Whether full-year 2026 revenue is reported at the high end of the Company's guidance ranges.
  • The timing of customers' capital investments and resulting quarterly order variability.

Analysis

InTest issued preliminary selected results for the quarterly period ended September 30, 2026 rather than final earnings. The company expects record Q3 orders of $48 million to $50 million, an increase of 28% to 33% compared with the third quarter of 2025. It also expects an estimated book-to-bill ratio above 1.3x. Management attributed the order strength to record back-end semiconductor orders.

Revenue is expected at the high end of the company's $33 million to $35 million Q3 guidance range, representing growth of more than 30% compared with $26.2 million in the third quarter of 2025. Management said shipments of semiconductor and other end-market orders booked in prior quarters are supporting revenue. It also expects full-year 2026 revenue at the high end of its guidance ranges, although the full-year range was not provided in this filing.

The expected September 30 backlog of $58 million to $60 million is up approximately 28% to 32% from $45.4 million at June 30, 2026. This build in backlog follows the expected record orders and provides a larger base of firm purchase orders for future revenue recognition. Management identifies AI-driven data center demand, customer capacity expansions, and demand for power-conversion, mixed-signal, and analog test solutions as demand drivers.

The release does not provide final GAAP or non-GAAP profitability, margin, EPS, cash flow, cash, debt, or capital-return results. Investors should therefore distinguish the favorable preliminary demand and revenue indicators from completed financial results. The company states that actual results may vary materially as closing procedures are completed, while also noting that order timing depends on customers' capital investments and that contracts may permit customer cancellation, termination, or suspension.

Management, verbatim

The increase in semiconductor demand we anticipated for the second half of the year has materialized, led by record back-end semiconductor orders. Demand for our advanced semiconductor test solutions is being driven by customers’ capacity expansions that are fueled in part by AI-driven data center demand. Our newer products, such as our high-powered chillers and advanced manipulators, are contributing substantially by addressing customers’ rising power conversion requirements and growing mixed-signal and analog test needs. With orders for semiconductor and other end-markets booked in prior quarters now shipping, we expect revenue for both the third quarter of 2026 and the full year to be at the high end of our guidance ranges. While order levels will vary from quarter to quarter with the timing of our customers’ capital investments, this quarter’s order activity has strengthened our backlog, positioning us for a strong finish to 2026 and to enter 2027 with promising momentum.

Rich Rogoff, President and CEO

Not in the filing

stated, not guessed
  • Final Q3 2026 revenue result
  • GAAP gross profit and gross margin
  • GAAP operating income or loss and operating margin
  • GAAP net income or loss
  • GAAP diluted EPS
  • Non-GAAP gross margin, operating income, net income, and EPS
  • Segment revenue and segment profitability
  • Operating cash flow
  • Free cash flow
  • Cash and cash equivalents
  • Debt
  • Share repurchases
  • Dividends
  • Capital expenditures
  • Full-year 2026 revenue guidance range
  • Guidance for gross margin, operating expenses, and tax rate
  • Prior guidance or prior outlook for comparison
  • Final Q3 2026 financial statements

AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

InTest Corp. (INTT) filed an 8‑K reporting its Q3 2026 preliminary results and guidance.

Company-level read

Ticker impact

$INTTBullishHigh confidence
Context

InTest issued guidance that Q3 orders will be $48M‑$50M and revenue $33M‑$35M, both at the high end of its previously disclosed range.

Expected impact

likely upward pressure as investors price in higher revenue and order growth

Evidence & confidence

The company highlighted record back‑end semiconductor orders and a backlog increase, suggesting momentum that could translate into near‑term price appreciation.

Market effects

Positive signal for semiconductor test equipment suppliers and related back‑end fab services.

U.S. semiconductor supply chain outlook reinforced.

May boost sentiment toward broader AI‑driven data‑center demand.

Counterpoint

If order growth stalls later in the year, the high‑end guidance could be revised down, leading to a pullback.

Key entities

  • InTest Corporation

    Provider of test and process technology solutions for semiconductors and other markets.

Every INTT earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$INTTLow

Why is inTest stock dropping 10% today?

inTest Corporation's stock dropped 10.2% to $13.50 in pre-open trading after a preliminary Q3 2026 update. The company reported expected Q3 orders of $48M-$50M, a 28%-33% YoY growth, but investors sold due to high expectations and technical overextension. Gross margin concerns persist, with Q2 2026 margins 500 basis points below guidance. The broader market is up slightly.

$INTTMedAI 8/10

InTest (INTT) Q2 2026 Earnings Call Transcript

InTest (INTT) reported Q2 2026 revenue of $35.3M, up 25.5% YoY, with semi orders $12.0M (+64% YoY) and backlog $45.4M (+19.8% YoY). Full-year guidance raised to $135M-$140M. Gross margin was 40.5% and adjusted EBITDA $2.2M. CFO cited a material weakness at Alfamation.

$INTTMed

InTest Reports Strong Second Quarter 2026 Revenue of $35.3 Million EPS of $0.04 and Adjusted EPS (Non-GAAP) of $0.09

INTEST CORP (INTT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Reports Strong Second Quarter 2026 Revenue of $35.3 Million EPS of $0.04 and Adjusted EPS (Non-GAAP) of $0.09 • Second quarter revenue up 25.5% year-over-year, driven lar

$INTTMed

Why is inTest stock climbing today?

inTest Corp (INTT) shares rose 1.7% in pre-open trading after Northland upgraded the stock to “outperform” from “market perform” and set a $15.00 price target. Northland cited inTest’s preliminary Q2 2026 revenue estimate of about $35M and raised full-year 2026 revenue guidance to $135M-$140M, while noting a planned 220 bps gross margin reduction.

$INTTMed

InTest Reports Preliminary Second Quarter 2026 Results

INTEST CORP (INTT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Reports Preliminary Second Quarter 2026 Results • Second Quarter Revenue Estimated to be Approximately $35 Million • Second Quarter Gross Margin Estimated to be Approxima

Med

Sartorius Stedim Biotech SA (SDMHF) Q3 2026 Earnings Call Highlights: Solid

Sartorius Stedim Biotech SA (SDMHF) reported 7.8% operational sales growth in constant currencies for the first nine months of 2026, with a robust EBITDA margin of 31.3%. Free cash flow increased by 58.5% to EUR264 million, and net debt to EBITDA improved to 2.26 times. The company confirmed its full-year guidance, expecting operational sales growth around the midpoint of 6% to 10% and an underlying EBITDA margin slightly above 31%.